The weeks following the definition of the party blocs set the tone for what this new legislature might looks like.

GlaxoSmithKline’s ViiV Healthcare has already shown that a two-drug HIV regimen can hang with its three-drug competitors. But now it has data showing it can do the same with administration just once per month

As more countries seek to control their health care spending, the Italian government is asking the World Health Assembly to adopt a resolution that would require drug makers to disclose their R&D and production costs, as well as prices charged for medicines and vaccines.

When a few months of treatment costs as much as a house, some patients are taking their lives and the law into their own hands to survive.